Synvivia
PrivateLast Round
Grant
Dec 15, 2024
Est. Valuation
$1.71M
Total Funding Raised
$4.38M
Company Overview
Synvivia is a biotechnology company that develops genetically engineered organisms and molecular switches controlled by small molecules to optimize biomanufacturing and ensure biocontainment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synvivia Comparables
Compare Synvivia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asimov | 66% | |
| Twist Bioscience Corporation | 61% | |
| Ginkgo Bioworks | 61% |
Synvivia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 15, 2024 | ||||
| Seed | Dec 11, 2023 | ||||
| Grant | Nov 1, 2022 | ||||
| Grant | Sep 1, 2022 | ||||
| Grant | Dec 1, 2021 | ||||
Grant | Sep 23, 2019 |
Synvivia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creative Ventures | Seed |
| California Innovation Fund | Seed, Grant |
| Y Combinator | Accelerator |
| National Institute of General Medical Sciences | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2021
Secured $256K from the National Science Foundation and California Innovation Fund.
Synvivia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Synvivia's valuation, stock price, and market status.
Is Synvivia a public or private company?
Synvivia is a private company.
What is the current stock price of Synvivia?
Synvivia is a private company, so its shares have no public market price. Caplight tracks Synvivia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synvivia worth (valuation)?
Synvivia's valuation is estimated at $1.7M based on funding round data.
Can I buy Synvivia stock?
Synvivia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synvivia's last funding round?
Synvivia's most recent funding round was Grant on December 15, 2024.
Who are the main investors in Synvivia?
Key investors in Synvivia include Y Combinator, National Institute of General Medical Sciences, National Science Foundation.
Will Synvivia IPO soon?
No public IPO plans have been announced for Synvivia.
How can I track Synvivia secondary market activity?
Caplight tracks bids, offers, and trades in Synvivia's shares on secondary markets.